New drug to slow Alzheimer's development — and more health headlines (opens original article in a new tab)
A new drug developed by ETH Zurich University molecular pharmacologists shows promise in slowing the progression of Alzheimer's disease.
- ETH Zurich University developed a compound to slow Alzheimer's progression.
- The drug is a promising Alzheimer's treatment.
- Research on the drug is ongoing.
Conversation
No comments yet
Threaded discussion is coming next — this is where the community conversation about this story will live.